Richard A. Young, Director at Syros Pharmaceuticals, Inc. (SYRS), sold 3,750 shares at $12.05 ($45K) on 2021-02-16, disclosed to the SEC on 2021-02-18.
Scheduled sale ($45k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| OMGA | SELL | 2023-06-05 | $40K | — | Filing → |
| OMGA | SELL | 2023-05-03 | $40K | — | Filing → |
| OMGA | SELL | 2023-04-10 | $40K | — | Filing → |